A 62-year-old male presented with fatigue, dizziness, palpitations, and pancytopenia, subsequently diagnosed with myelodysplastic neoplasm (MDS) with increased blasts 2, alongside mutations in DDX41 and TP53 via a targeted 521-gene hematologic disorder panel. The gene discussed is TP53; the disease is myelodysplastic syndrome.